Los gobiernos de América Latina han confirmado más de 3,5 millones de casos de dengue en los tres primeros meses de 2024, frente a los 4,5 millones de todo 2023. Es una advertencia de un panorama cambiante para la enfermedad.
A public research institute in Brazil has proved a new shot protects against the disease, but can’t make it fast enough to stop the huge outbreak sweeping Latin America.
One company is going to great lengths to build it up, but it will be years before it returns to the minimum level.
Pain management is an inexact science; there is plenty of blame to go around for the abuse of such drugs.
El ensayo duró solo un año y no es concluyente, pero dio señales de esperanza a algunos expertos.
Results of a large clinical trial found the treatment did not work any better than a placebo.
Here’s why some products have been pulled from store shelves, and what to know to protect your eyes.
The trial lasted only one year but offered embers of hope to some experts.
Varios jueces cuestionaron la conveniencia de aplicar restricciones nacionales a la mifepristona porque sería la primera vez que un tribunal cuestiona el juicio de los expertos de la FDA sobre un medicamento.
Several justices questioned the remedy of applying nationwide restrictions to mifepristone because it would be the first time a court had second-guessed the F.D.A.’s regulatory authority.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.